These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33538758)

  • 21. Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population.
    Rojas-Campos E; Ruvalcaba-Contreras N; Campos-Mariz A; Aguilar-Campos A; Andrade-Sierra J; Cerrillos-Gutiérrez JI; Medina-Pérez M; Evangelista-Carrillo L; Banda A; Cueto-Manzano AM
    Arch Med Res; 2024 Jun; 55(4):103008. PubMed ID: 38824883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015).
    Al Salmi I; AlRukhaimi M; AlSahow A; Shaheen FA; Al-Ghamdi SM; AlAli F; AlGhareeb S; Al Maimani Y; AlGhonaim M; Bieber B; Tentori F; Pisoni RL;
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):62-80. PubMed ID: 27991480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and pattern of chronic kidney disease-mineral bone disorders among hemodialysis patients in kano, northwest nigeria.
    Abdu A; Abdu A; Arogundade FA
    Ann Afr Med; 2019; 18(4):191-195. PubMed ID: 31823953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.
    Ambrus C; Molnar MZ; Czira ME; Rosivall L; Kiss I; Remport A; Szathmari M; Mucsi I
    Int Urol Nephrol; 2009 Dec; 41(4):1029-38. PubMed ID: 19701690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary hyperparathyroidism among Nigerians with chronic kidney disease.
    Gimba ZM; Abene EE; Agbaji OOO; Agaba EI
    Afr Health Sci; 2018 Jun; 18(2):446-457. PubMed ID: 30602972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce.
    Bacchetta J; Schmitt CP; Bakkaloglu SA; Cleghorn S; Leifheit-Nestler M; Prytula A; Ranchin B; Schön A; Stabouli S; Van de Walle J; Vidal E; Haffner D; Shroff R
    Pediatr Nephrol; 2023 Sep; 38(9):3163-3181. PubMed ID: 36786859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alkaline Phosphatase, iPTH and Bone Turnover Markers in Chinese Advanced Chronic Kidney Disease Patients.
    Liu Y; He Q
    Clin Lab; 2015; 61(7):839-43. PubMed ID: 26299086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CKD-MBD biomarkers and CKD progression: an analysis by the joint model.
    D'Arrigo G; Mallamaci F; Pizzini P; Leonardis D; Tripepi G; Zoccali C
    Nephrol Dial Transplant; 2023 Mar; 38(4):932-938. PubMed ID: 35790138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
    Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R
    J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mineral and bone disorder and longterm survival in a chronic kidney disease grade 3b-4cohort.
    Rios P; Silvariño R; Sola L; Ferreiro A; Lamadrid V; Fajardo L; Gadola L
    Ren Fail; 2022 Dec; 44(1):1356-1367. PubMed ID: 35946486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry.
    Tangri N; Wagner M; Griffith JL; Miskulin DC; Hodsman A; Ansell D; Naimark DM
    Am J Kidney Dis; 2011 Mar; 57(3):415-21. PubMed ID: 21131115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of plasma neutrophil gelatinase-associated lipocalin with parameters of CKD-MBD in maintenance hemodialysis patients.
    Jia XY; Wei K; Chen J; Xi LH; Kong XL; Wei Y; Wang L; Wang ZS; Liu YP; Liang LM; Xu DM
    J Bone Miner Metab; 2021 Nov; 39(6):1058-1065. PubMed ID: 34392464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.
    Haffner D; Schaefer F
    Pediatr Nephrol; 2013 Apr; 28(4):537-45. PubMed ID: 22893310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005-2012.
    Liu CT; Lin YC; Lin YC; Kao CC; Chen HH; Hsu CC; Wu MS
    Sci Rep; 2017 Feb; 7(1):33. PubMed ID: 28232731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.
    Yun HJ; Ryoo SR; Kim JE; Choi YJ; Park I; Shin GT; Kim H; Jeong JC
    BMC Nephrol; 2020 Jul; 21(1):299. PubMed ID: 32711466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: A study from a tertiary care hospital in India.
    Vikrant S; Parashar A
    Indian J Endocrinol Metab; 2016; 20(4):460-7. PubMed ID: 27366711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease.
    Raji YR; Ajayi SO; Adeoye AM; Amodu O; Tayo BO; Salako BL
    Afr Health Sci; 2022 Mar; 22(1):344-351. PubMed ID: 36032486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.
    Noordzij M; Korevaar JC; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT;
    Am J Kidney Dis; 2005 Nov; 46(5):925-32. PubMed ID: 16253734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular mortality in peritoneal dialysis: the impact of mineral disorders.
    Truyts C; Custodio M; Pecoit-Filho R; Moraes TP; Jorgetti V
    J Bras Nefrol; 2021; 43(2):182-190. PubMed ID: 33576763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.